Skip to main content

Table 2 Schedule of Activities that study subjects will go through from beginning to end

From: Randomized, placebo controlled, double blinded pilot superiority phase 2 trial to evaluate the effect of curcumin in moderate to severe asthmatics

Procedures Screening
Day-7 to -1
Enrollment/baseline
Visit 1, Day 1
Study visit 2
Week 4
Study visit 3
Week 8
Study visit 4
Week 12
Follow up
Week 16
Informed consent X      
Demographics X      
Medical history X      
Randomization   X     
Administer study intervention   X  
Concomitant medication review X X X X X  
Physical exam (including height and weight) X X    X  
Vital signs X X    X  
ACT Scoring/ Questionnaire   X X X X  
Spirometry (FVC, FEV1)   X X X X  
Blood studies (eosinophils, IgE)   X    X  
Exhaled nitric oxide   X X X X  
INR and PTT   X     
Urine pregnancy test (if applicable)   X X X X  
Adverse event review and evaluation   X X X X X
Complete Forms X X X X X X
  1. ACT Asthma control test, FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, IgE immunoglobulin E, INR international normalized ratio, PTT partial thromboplastin time